Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12052
Full Text
Open PDFAbstract
Available in full text
Date
March 5, 2019
Authors
Publisher
Wiley